A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The clinical outcome of extranodal natural killer T-cell lymphoma (ENKTL) has improved substantially as a result of new treatment strategies with non-anthracycline-based chemotherapies and upfront use of concurrent chemoradiotherapy or radiotherapy. A new prognostic model based on the outcomes obtained with these contemporary treatments was warranted.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet Oncol.

Title: The Lancet. Oncology

Publisher: Elsevier BV

ISSN (Electronic): 1474-5488

ISSN (Print): 1470-2045

Publication date (Electronic): Mar 2016

Volume: 17

Issue: 3

Affiliations

[1 ] Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

[2 ] University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.

[3 ] Centre Hospitalier Universitaire Limoges, Limoges, France.

[4 ] National University Cancer Institute, Singapore, Singapore.

[5 ] National Cancer Centre, Singapore, Singapore.

[6 ] Sun Yat-sen University Cancer Center, Guangzhou, China.

[7 ] Korea University Anam Hospital, Seoul, South Korea.

[8 ] Ampang Hospital, Ampang, Malaysia.

[9 ] Okayama University Hospital, Okayama, Japan.

[10 ] Shinshu University, Matsumoto, Japan.

[11 ] Korea Cancer Center Hospital, Seoul, South Korea.

[12 ] Yonsei University College of Medicine, Seoul, South Korea.

[13 ] Ajou University School of Medicine, Suwon, South Korea.

[14 ] Chonnam National University Hwasun Hospital, Gwangju, South Korea.

[15 ] University of Ulsan College of Medicine, Ulsan, South Korea.

[16 ] Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, South Korea.

[17 ] Korea University Guro Hospital, Seoul, South Korea.

[18 ] Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.

[19 ] National Cheng Kung University Hospital, Tainan, Taiwan.

[20 ] Biostatistics and Clinical Epidemiology Center, Samsung Medical Center, Seoul, South Korea.

[21 ] Hyogo Cancer Center, Akashi, Hyogo, Japan.

[22 ] University of Texas MD Anderson Cancer Center, Houston, TX, USA.

[23 ] Stanford University, Stanford, CA, USA.

[24 ] Aarhus University Hospital, Aarhus, Denmark.

[25 ] Asklepios Hospital St Georg, Hamburg, Germany.

[26 ] Shimane University, Shimane, Japan.

[27 ] Queen Mary Hospital, Pokfulam Road, Hong Kong, China.

[28 ] Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: wskimsmc@skku.edu.

Article

Publisher Item ID: S1470-2045(15)00533-1

DOI: 10.1016/S1470-2045(15)00533-1

PubMed ID: 26873565

SO-VID: 4b07d9dd-da26-447a-b979-068acb383376

History

Data availability:

Comments

Comment on this article

scite_

Cited by 157

See all cited by

- Version 1